Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy.
Friedes BD, DiNofia AM, Iannone E, Li Y, Rheingold SR, Barz Leahy A, Wray L, Callahan C, Baniewicz D, Vernau L, Getz KD, Aplenc R, Maude SL, Grupp SA, Myers RM.
Friedes BD, et al. Among authors: myers rm.
Blood Adv. 2024 Nov 20:bloodadvances.2024014518. doi: 10.1182/bloodadvances.2024014518. Online ahead of print.
Blood Adv. 2024.
PMID: 39565957
No abstract available.